Browsing Category
New York
Covid oral pill could be ready by year-end : Pfizer CEO
US-based pharmaceutical major Pfizer's Chief Executive Officer Albert Bourla said that the company's Covid-19 oral antiviral pill, which is in early-stage trials, could be ready by the end of the year, the media reported.According to CNBC,…
Covid’s spike protein plays key role in illness: Study
SARS-CoV-2's distinctive "spike" proteins have been known to infect its host by latching on to healthy cells, but scientists have, in a new study, showed that they also play a key role in the disease.The paper, published in the journal…
Gene changes may explain symptoms in Covid survivors
SARS-CoV-2, the virus that causes Covid-19, is covered in tiny spike proteins. This spike protein can bring about long-term gene expression changes, finds a new cell study that can explain why some Covid-19 patients -- referred to as Covid…
Hepatitis C drugs combined with Remdesivir more effective
US researchers have found that combining Remdesivir -- a drug currently approved for treating Covid-19 patients -- with repurposed drugs for hepatitis C virus (HCV) is 10 times more effective at slowing down SARS-CoV-2, the virus that…
How diabetes, cancer & pesticide exposure raises Covid risk
People with metabolic diseases like Type-2 diabetes and cancer as well as those exposed to organophosphate pesticides can be at an increased risk of Covid-19 infection, finds a new study performed in human lung airway cells.The study, led…
Patients hospitalised with Covid at risk of heart failure
Patients hospitalised with Covid-19 may be at risk of developing heart failure even if they do not have a previous history of heart disease or cardiovascular risk factors, according to a new study.While these instances are rare, doctors…
Gilead to help speed up Remdesivir availability in India
Pharmaceutical major Gilead Sciences has announced that the company is providing its voluntary licensing partners with technical assistance, support for the addition of new local manufacturing facilities and the donation of active…
US supplies of AstraZeneca vaccine to India could take ‘weeks’
The US is "looking at options" to ship millions of AstraZeneca vaccines to India but that can happen only after it clears federal safety review, the White House said on Monday. This process could take a few "weeks".Approximately 10 million…
US to rush vaccine raw materials, anti-Covid supplies to India
In a break from the America First policy, President Joe Biden's administration is "working round the clock" to immediately send India raw material needed for making Covishield and other products needed in the fight against the COVID-19…
False sense that pandemic was over behind fresh Covid peaks
It is not herd immunity that is causing fresh peaks in Covid caseloads in several countries, including India, but a time-dependent social activity and changing people behaviours due to pandemic fatigue that is causing the lethal second wave…